Financial Performance Highlights (FY 2025-26)

Privi Speciality Chemicals delivered exceptional financial results with revenue of ₹2,582.92 Crores (21.73% growth YoY), EBITDA of ₹665.45 Crores (40.35% growth YoY), and Profit After Tax of ₹327.54 Crores (75.16% growth YoY). The company maintained strong export contribution at 67% of total revenue with sales volume of 42,389 metric tons (6.5% growth YoY). EBITDA margin expanded to 25.76% from 22.35% in the previous year.

AGM Details and Corporate Actions

The 41st Annual General Meeting will be held on August 7, 2026, through video conferencing with remote e-voting available from August 4-6, 2026. Key resolutions include approval of a final dividend of ₹10 per equity share (100%) with record date of July 31, 2026, and re-appointment of directors including Mr. Mahesh P Babani (Chairman & MD) and Mr. Bhaktavatsala Doppalapudi Rao (Executive Director).

Operational and Expansion Initiatives

The company operates 7 manufacturing facilities with 48,000 MTPA installed capacity and is progressing toward its 5K:1K vision targeting ₹5,000 crores revenue and ₹1,000 crores EBITDA by FY30. Phase I expansion completion is expected by mid-August 2026 (capacity to 54,000 MTPA), with Phase II and III targeted for September 2027 and September 2028 respectively. Total planned capex is approximately ₹1,400 crores over 3.5 years.

Corporate Developments

A Composite Scheme of Arrangement provides for amalgamation of Privi Fine Sciences Private Limited and Privi Biotechnologies Private Limited with Privi Speciality Chemicals Limited with appointed date of October 1, 2025. The PRIGIV joint venture received equity infusion of ₹50 crores (Privi: ₹25.50 crores, Givaudan: ₹24.50 crores) and achieved positive PAT in Q4 FY26 with expected non-interest bearing trade advance of ₹180 crores from Givaudan.

Sustainability and ESG Performance

Privi maintains EcoVadis Platinum Certification and comprehensive sustainability metrics: 100% of employees received human rights training, 90% plant assessments completed, and net zero roadmap targeting 2032 for near-term goals. Environmental performance includes total energy consumption of 2,767,392 GJ, Scope 1 emissions of 243,070 MTCO2e, water consumption of 691.38 million liters, and achievement of Zero Liquid Discharge at multiple units. CSR spending was ₹2.71 crores focused on education, health, and environment.

Financial Position and Assets

The Group's property, plant and equipment had gross carrying amount of ₹198,811.22 lakhs with additions of ₹14,647.60 lakhs during the year. Capital work-in-progress amounted to ₹29,764.82 lakhs for various expansion projects. Right-of-use assets stood at ₹9,283.70 lakhs primarily for land, while intangible assets totaled ₹3,768.04 lakhs with ₹1,611.82 lakhs under development.

Governance and Compliance

The Board and committee structure includes Audit, Nomination and Remuneration, Stakeholders Relationship, Risk Management, and CSR committees. Auditors B S R & Co. LLP provided unqualified opinion with key audit matter around revenue recognition timing. The company maintains CRISIL AA- (Stable) rating for long-term facilities and CRISIL A1+ for short-term facilities.

Signatories and Compliance Statement

The documents are signed by company representatives including Mahesh Babani (Chairman & MD), D. B. Rao (Executive Director), Narayan S Iyer (CFO), Ashwini Shah (Company Secretary), and Jayesh T Thakkar (Partner, B S R & Co. LLP). Financial statements comply with Indian Accounting Standards (Ind AS), Companies Act 2013, and SEBI Listing Regulations.